Biodexa Pharmaceuticals (BDRX) Short Interest Ratio & Short Volume → Elon Musk’s Next Move Will Disrupt AI Forever (From InvestorPlace) (Ad) Free BDRX Stock Alerts $1.08 +0.11 (+11.47%) (As of 01:07 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Biodexa Pharmaceuticals Short Interest DataCurrent Short Volume2,060,000 sharesPrevious Short Volume189,600 sharesChange Vs. Previous Month+986.50%Dollar Volume Sold Short$3.11 millionShort Interest Ratio / Days to Cover0.6Last Record DateApril 30, 2024Outstanding Shares1,290,000 sharesPercentage of Shares Shorted159.69%Today's Trading Volume247,098 sharesAverage Trading Volume2,272,221 sharesToday's Volume Vs. Average11% Short Selling Biodexa Pharmaceuticals ? Sign up to receive the latest short interest report for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBDRX Short Interest Over TimeBDRX Days to Cover Over TimeBDRX Percentage of Float Shorted Over Time Ad InvestorPlaceCrypto Pioneer Says: “The last crypto bull market has begun.”Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos… Biodexa Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20242,060,000 shares $3.11 million +986.5%N/A0.6 $1.51 4/15/2024189,600 shares $157,974.72 +183.8%N/A0.1 $0.83 3/31/202466,800 shares $108,216.00 -34.9%N/A0 $1.62 3/15/2024102,600 shares $120,042.00 -32.3%N/A0.2 $1.17 2/29/2024151,600 shares $192,532.00 -37.1%N/A0.3 $1.27 2/15/2024241,100 shares $383,349.00 +414.1%N/A0.2 $1.59 Get the Latest News and Ratings for BDRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/202446,900 shares $75,509.00 +3.3%N/A0.1 $1.61 1/15/202445,400 shares $91,254.00 -46.7%N/A0.1 $2.01 12/31/202385,100 shares $228,068.00 -51.8%N/A0.1 $2.68 12/15/2023176,500 shares $524,205.00 -43.3%N/A0.3 $2.97 11/30/2023311,300 shares $1.13 million +3,044.4%N/A0.5 $3.62 11/15/20239,900 shares $25,344.00 -5.7%N/A0 $2.56 10/31/202310,500 shares $39,690.00 -61.5%N/A0 $3.78 10/15/202327,300 shares $132,132.00 +875.0%N/A0.1 $4.84 9/30/20232,800 shares $13,972.00 -63.6%N/A0 $4.99 9/15/20237,700 shares $47,586.00 -64.2%N/A0 $6.18 8/31/202321,500 shares $171,785.00 -28.3%N/A0 $7.99 8/15/202330,000 shares $148,800.00 -50.3%N/A0.1 $4.96 7/31/202360,300 shares $328,635.00 -27.1%N/A0.1 $5.45 7/15/202382,700 shares $445,753.00 +100.2%N/A0.3 $5.39 6/30/202341,300 shares $226,654.40 -85.5%N/A0.3 $5.49 6/15/2023284,600 shares $22,141.88 +156.2%N/A0.1 $0.08 5/31/2023111,100 shares $9,332.40 -37.8%N/A0 $0.08 5/15/2023178,700 shares $40,475.55 No ChangeN/A0.1 $0.23 BDRX Short Interest - Frequently Asked Questions What is Biodexa Pharmaceuticals' current short interest? Short interest is the volume of Biodexa Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 2,060,000 shares of BDRX short. Learn More on Biodexa Pharmaceuticals' current short interest. What is a good short interest ratio for Biodexa Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BDRX shares currently have a short interest ratio of 1.0. Learn More on Biodexa Pharmaceuticals's short interest ratio. Is Biodexa Pharmaceuticals' short interest increasing or decreasing? Biodexa Pharmaceuticals saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 2,060,000 shares, an increase of 986.5% from the previous total of 189,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Biodexa Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Biodexa Pharmaceuticals: GRI Bio, Inc. (0.46%), Panbela Therapeutics, Inc. (2.36%), Lucy Scientific Discovery Inc. (3.32%), NeuBase Therapeutics, Inc. (0.51%), Sunshine Biopharma, Inc. (29.84%), InMed Pharmaceuticals Inc. (5.92%), Evelo Biosciences, Inc. (2.11%), 180 Life Sciences Corp. (5.29%), SciSparc Ltd. (4.18%), PainReform Ltd. (1.17%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Biodexa Pharmaceuticals stock? Short selling BDRX is an investing strategy that aims to generate trading profit from Biodexa Pharmaceuticals as its price is falling. BDRX shares are trading up $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Biodexa Pharmaceuticals? A short squeeze for Biodexa Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BDRX, which in turn drives the price of the stock up even further. How often is Biodexa Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BDRX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: GRI Bio Short Interest Data Panbela Therapeutics Short Interest Data Lucy Scientific Discovery Short Interest Data NeuBase Therapeutics Short Interest Data Sunshine Biopharma Short Interest Data InMed Pharmaceuticals Short Interest Data Evelo Biosciences Short Interest Data 180 Life Sciences Short Interest Data SciSparc Short Interest Data PainReform Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BDRX) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxHUGE BUY ALERT: Move Fast, Musk...Stansberry ResearchDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals